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Background: The aim of the present study was to compare the osteogenic potential of mesenchymal stem cells
extracted from the bone marrow (BM-MSCs) and adipose tissue (AD-MSCs) of young dogs. The following parameters
were assessed: dimethyl thiazolyl diphenyl tetrazolium (MTT) conversion, alkaline phosphatase (ALP) activity, collagen
and mineralised matrix synthesis, and the expressions of osterix, bone sialoprotein (BSP), and osteocalcin (OC).
Results: MTT conversion was greater in BM-MSCs compared to AD-MSCs after 14 and 21 days of differentiation; ALP
activity was greater in differentiated AD-MSCs on day 7; collagen synthesis was greater in BM-MSCs on days 14 and 21;
the percentage of mineralized area per field was greater in BM-MSCs compared to AD-MSCs; osterix expression was
greater in BM-MSCs in days 14 and 21, and BSP and OC expression levels were greater in BM-MSCs at all the investigation
time-points.
Conclusions: It was concluded that the osteogenic potential was greater in BM-MSCs than AD-MSCs when extracted
from young dogs.
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The aim of cell therapy research is to produce successful
cell cultures that can be used in the treatment of various
disorders. However, it is a subject of on-going research,
and many questions remain unanswered. The available
data show that there are various populations of mesen-
chymal stem cells (MSCs) that exhibit variable patterns
of proliferation and differentiation within the same indi-
vidual [1]. These populations are unevenly distributed in
the tissues, and the tissue site determines the prolifera-
tive and differentiation potential of MSCs isolated from
the same individual [2]. Some studies have shown that
the osteogenic potential of MSCs may vary as a function
of tissue type [3,4], collection site [5], animal species [6],
age [7,8], state of health [9], and performance of physical
activity on a daily basis [7,10].* Correspondence: cleuzaufmg@gmail.com
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unless otherwise stated.In vitro comparison of the osteogenic potential of vari-
ous MSC sources allows for the selection of the most
promising MSCs for bone regeneration therapy. Bone
marrow [11] and adipose tissue [12] are considered to
be the main sources of MSCs due to the presence of
large numbers of cells and the simplicity of collection
and isolation. However, the best source of MSCs for
bone regeneration therapy remains unknown [2]. Few
studies have compared bone marrow and adipose tissue
MSCs in dogs. One such study compared the in vivo
osteogenic potential of MSCs from bone marrow, adi-
pose tissue, and umbilical cord blood in treating bone
defects in dogs [4]. However, no study has yet compared
the in vitro osteogenic potential of MSCs from the bone
marrow and adipose tissue of the same animal.
Therefore, the aim of the present study was to perform
a quantitative assessment of the osteogenic potential of
bone marrow (BM-MSCs) and adipose tissue (AD-MSCs)
MSCs from young dogs, in order to identify the best
source of MSCs for bone regeneration therapy in dogs.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Both BM-MSCs and AD-MSCs exhibited an elongated
fusiform shape. Phenotype characterization found high
expression of the stem cell markers CD90 (80.04% ± 1.96)
and CD29 (96.00% ± 3.00) in BM-MSCs and CD90
(60.94% ± 4.45) and CD29 (77.08% ± 2.88) in AD-MSCs.
The expression of haematopoietic cell markers was low:
CD45 (1.45% ± 0.60) and CD34 (1.53% ± 0.39) in BM-
MSCs and CD45 (1.54% ± 0.46) and CD34 (0.88% ± 0.30)
in AD-MSCs.
Conversion of MTT into formazan and alkaline phosphatase
activity
All of the groups exhibited an increased ability to convert
MTT into formazan crystals throughout the culture
period independent of the medium used. MSCs cultured
in basal medium exhibited greater MTT conversion
compared to those cultured in osteogenic medium on days
14 and 21. When subjected to osteogenic differentiation,
BM-MSCs exhibited greater MTT conversion compared
to AD-MSCs under the same culture conditions on days
14 and 21 (Figure 1).
Except for AD-MSCs on day 21, all of the cells exhibited
greater ALP activity when cultured in osteogenic medium.
Relative to the cultures in osteogenic medium, AD-MSCs
exhibited greater ALP activity on day 7 compared to BM-
MSCs. This increased activity was not found at the later
time-points of assessment (days 14 and 21) (Figure 2).
Collagen synthesis, percentage of cells, and mineralised
matrices
All of the groups exhibited an increase in the percentage of
cells per field throughout the culture period regardless of
the medium used. MSCs in basal medium systematicallyFigure 1 Mean and standard deviation values of MTT conversion into
DMEM (basal medium) or osteogenic medium on days 7, 14, and 21 *exhibited a higher number of cells per field compared to
those subjected to osteogenic differentiation, although the
initial number of cells was the same. The number of cells
per field corresponding to undifferentiated BM-MSCs was
higher compared to that of AD-MSCs under the same
culture conditions at all the investigated time-points. When
cultured in osteogenic medium, the number of cells per
field corresponding to BM-MSCs was higher than that of
AD-MSCs under the same culture conditions on days 7
and 21 (Figure 3).
Except for AD-MSCs on days 14 and 21, collagen syn-
thesis was higher in the groups subjected to osteogenic
differentiation compared to the undifferentiated groups.
On days 14 and 21, BM-MSCs exhibited greater collagen
synthesis compared to AD-MSCs under the same culture
conditions, and the opposite result was found on day 7
(Figure 4).
Both cell types exhibited the morphologic changes
typical of osteogenic differentiation on day 7 in osteogenic
medium, including nodule formation and the production
of mineralised matrix. In the differentiated groups, the
percentage of mineralised matrix increased throughout
the culture period, while the formation of mineralised
matrix was minimal in the undifferentiated groups at less
than 3% per field. Relative to the cells subjected to osteo-
genic differentiation, the percentage of mineralised matrix
per field was systematically higher in BM-MSCs compared
to AD-MSCs (Figures 5 and 6).
Gene transcripts of osteogenic differentiation
Osterix expression was higher in MSCs subjected to
osteogenic differentiation compared to those kept in
basal medium and those of osteoblasts. On days 14 and
21 of osteogenic differentiation, osterix expression was
greater in BM-MSCs compared to AD-MSCs under the
same culture conditions, and no difference was found on
day 7 (Figure 7).
The expression of BSP by MSCs was lower compared to
osteoblasts. However, BSP expression by BM-MSCs in
osteogenic medium on days 7 and 21 was similar comparedformazan crystals in canine BM-MSC and AD-MSC cultures in
(P < 0.05).
Figure 2 Mean and standard deviation values of alkaline phosphatase activity in canine BM-MSC and AD-MSC cultures in DMEM (basal
medium) or osteogenic medium on days 7, 14, and 21 *(P < 0.05).
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to osteogenic differentiation was higher than that by MSCs
kept in basal medium. Relative to the cells subjected to
osteogenic differentiation, the expression of BSP by BM-
MSCs was higher compared to AD-MSCs (Figure 8).
The expression of OC was systematically higher in the
MSCs subjected to osteogenic differentiation compared
to the undifferentiated MSCs that were cultured in basal
medium and osteoblasts. The expression of OC by BM-
MSCs subjected to osteogenic differentiation was system-
atically higher compared to AD-MSCs under the same
culture conditions (Figure 9).
Discussion
The elongated shape of BM-MSCs and AD-MSCs, as
well as the observed phenotypic characteristics of high
stem cell marker expression and low haematopoietic cell
marker expression, indicated successful isolation of MSCs
as per the defined standards of the International Society
for Cellular Therapy [13] and reports by other authors
[11,14].
The lower level of MTT conversion into formazan
crystals exhibited by the MSCs subjected to osteogenic
differentiation was suggestive of lower mitochondrial
activity, as found by other authors [1]. This observationFigure 3 Mean and standard deviation of the percentage of cells per
medium) or osteogenic medium on days 7, 14, and 21 *(P < 0.05).may be attributed not only to the lower metabolic activity
of differentiated cells compared to undifferentiated MSCs
but also to the lower number of cells in the groups
subjected to osteogenic differentiation, as seen in the
present study. As differentiation progresses, cellular prolif-
erative capacity decreases, and the cell activity shifts to
the synthesis of proteins specific to the differentiated cell
and the extracellular bone matrix components [15].
The greater MTT conversion found in the BM-MSCs
subjected to differentiation indicated greater activity in
those cells compared to AD-MSCs under the same cul-
ture conditions. This finding represents an advantage in
the use of BM-MSCs; the more active the cell, the more
extracellular matrix it produces, thus promoting bone
regeneration when used for therapeutic purposes.
The gradual and progressive increase of ALP activity
during the process of osteogenic differentiation found
in both BM-MSCs and AD-MSCs suggested successful
osteogenic differentiation [6,10]. The enzyme ALP is
present in the osteoblast membrane, participates in the
synthesis and mineralisation of the bone matrix, and is
one of the most widely used markers of in vitro osteo-
genic differentiation [1]. Its expression may increase
up to 27 times during the process of osteogenic differ-
entiation [16].field in canine BM-MSC and AD-MSC cultures in DMEM (basal
Figure 4 Mean and standard deviation values of collagen content in canine BM-MSC and AD-MSC cultures in DMEM (basal medium) or
osteogenic medium on days 7, 14, and 21 *(P < 0.05).
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per field exhibited by BM-MSCs compared to AD-MSCs
subjected to osteogenic differentiation indicate not only
improved osteogenic differentiation in the former but
also greater capacity for extracellular matrix synthesis
under the same culture conditions. Type I collagen is
the main component of the organic bone matrix, corre-
sponding to 90% of its composition. It is considered an
early marker of osteogenic differentiation and may be
expressed by osteoprogenitor cells, pre-osteoblasts, and
osteoblasts [17].
The presence of mineralised nodules beginning at day
7 in both MSC types cultured in osteogenic medium
confirmed the occurrence of differentiation in these cells.
Following osteogenic differentiation, the MSCs become
cuboid or polygonal in shape, resembling osteoblasts, and
they cluster concentrically, forming mineralised nodulesFigure 5 Culture of mesenchymal stem cells extracted from the bone m
dogs subjected to osteogenic differentiation at days 7 (A), 14 (B), and 2
The mineralised area per field was greater in BM-MSCs (1) compared to AD-M[1]. Such nodules are considered reliable indicators of
in vitro osteogenic differentiation [18].
The increased osterix expression in the BM-MSC and
AD-MSC cultures subjected to differentiation is a relevant
indicator of osteogenic differentiation because this tran-
scription factor is indispensable for differentiation. Osterix
participates in the transformation of pre-osteoblasts into
mature osteoblasts, which is the final step of differenti-
ation [19]. Furthermore, increased osterix expression by
MSCs subjected to osteogenic differentiation is considered
to be an indicator of differentiation in canines [12].
The greater osterix expression exhibited by BM-MSCs
on days 14 and 21 also suggested improved osteogenic
differentiation of these cells compared to AD-MSCs under
the same culture conditions.
The increased expression of BSP and OC during the
differentiation found in the present study is a reflectionarrow (BM-MSCs) (1) and adipose tissue (AD-MSCs) (2) of young
1 (C). The mineralised nodules were stained by the Von Kossa technique.
SCs (2) at all of the investigated time-points. Bar = 350 μm.
Figure 6 Mean and standard deviation of the percentage of mineralised area per field in canine BM-MSC and AD-MSC cultures in
DMEM (basal medium) or osteogenic medium on days 7, 14, and 21 *(P < 0.05).
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MSCs and AD-MSCs. The non-collagen matrix proteins
are considered markers of osteogenic differentiation, and
they are closely related to the production and mineral-
isation of the extracellular matrix [15].
The greater expression of BSP and OC by BM-MSCs
found in the present study during the entire process of
differentiation gives further proof of their improved
osteogenic differentiation compared to AD-MSCs. BSP
is a protein that initiates the process of nucleation and
deposition of hydroxyapatite in the bone matrix. Increased
BSP expression reflects the final stage of differenti-
ation and the onset of matrix mineralisation. It may be
expressed by pre-osteoblasts and osteoblasts [16], and
increased expression was found in the osteogenic differ-
entiation of AD-MSC [5].
Osteocalcin is a bone-specific glycoprotein that pro-
motes matrix mineralisation. It is expressed by osteoblasts
and, therefore, reflects the end of the differentiation and
maturation of the bone matrix. It is considered a late
and more specific marker of osteogenic differentiation
[17,19]. Increasing levels of OC expression during osteo-
genic differentiation of BM-MSCs and AD-MSCs has also
been reported by other authors [12,14].
The greater expression of markers of osteogenic differ-
entiation, together with greater collagen synthesis andFigure 7 Mean and standard deviation of relative quantification of os
medium) or osteogenic medium on days 7, 14, and 21. The data are elarger mineralised areas exhibited by BM-MSCs compared
to AD-MSCs found in the present study, confirmed the
greater osteogenic potential of BM-MSCs in young
dogs. Similar results were reported by Im et al. [3], who
compared the osteogenic potential of BM-MSCs and
AD-MSCs in humans.
Conclusion
To conclude, BM-MSCs showed greater osteogenic poten-
tial compared to AD-MSCs when extracted from young
dogs.
Methods
The present study complied with international standards
for animal wellbeing and was approved by the animal
experimentation ethics committee (Comitê de Ética em
Experimentação Animal - CETEA) of the Federal Univer-
sity of Minas Gerais (Universidade Federal de Minas
Gerais – UFMG) (protocol no. 157/2009).
Harvesting of stem cells and phenotype characterization
Three male mongrel dogs, aged 129 ± 8.29 days and
average body weight of 10.17 ± 0.85 kg were used in the
study. They were clinically healthy, with negative result
for Leishmaniasis and normal total blood count and
urinalysis. The animals were given 1 mg/kg xylazineterix gene transcription by qRT-PCR of MSCs in DMEM (basal
xpressed relative to osteoblasts (dotted line) *(P < 0.05).
Figure 8 Mean and standard deviation of bone sialoprotein (BSP) gene transcription of canine BM-MSC and AD-MSC in DMEM (basal
medium) or osteogenic medium on days 7, 14, and 21 as measured by qRT-PCR. The data are expressed relative to osteoblasts (dotted
line) *(P < 0.05).
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lar (IM) route, 15 mg/kg ketamine (Vetanarcol, Konig,
São Paulo, Brazil) IM for anaesthetic induction and
preparation for surgery, and 3 mg/kg propofol (Fresofol,
Fresenius Kabi, São Paulo, Brazil) via the intravenous
route for intubation and maintenance of anaesthesia.
Meloxicam (Maxicam, Ouro Fino, São Paulo, Brazil) was
given at 0.2 mg/kg IM every 24 hours over 3 days as an
analgesic. For harvesting bone marrow, a puncture was
performed on the tibial plateau, and 1 mL of bone marrow
was collected into 0.5 mL of heparin sodium (Parinex,
Hipolabor, São Paulo, Brazil) from each animal, totalling
3 mL. One cm3 of adipose tissue was collected from the
subcutaneous gluteal area of each animal, totalling 3 cm3
of final sample. The bone marrow sample was centrifuged
at 1,400 rpm for 10 minutes, the supernatant was
discarded, and the pellet was plated and cultured in
T75 flasks (Sarstedt, NC, USA) containing low-glucose
Dulbecco's modified Eagle's medium – DMEM (Gibco,
CA, USA) enriched with gentamycin (60 μg/L), penicillin
(100 U/mL), streptomycin (100 μg/mL), amphotericin
(25 μg/mL) (PSA, Sigma-Aldrich, USA), and 10% foetal
bovine serum (FBS, Soralis, Brazil). The flasks were
incubated in a 5% CO2 incubator at 37°C, and 48 hours
later, the cells were washed with 0.15 M PBS. The
adipose tissue sample was washed with 0.15 M PBS andFigure 9 Mean and standard deviation of osteocalcin (OC) gene trans
or osteogenic medium on days 7, 14, and 21 of osteogenic differenti
osteoblasts (dotted line) *(P < 0.05).digested in 20 mL of 0.1% w/v collagenase B solution
(Roche, Penzberg, Germany). For the purpose of digestion,
the sample was fragmented into 2-mm particles and incu-
bated in a 5% CO2 incubator at 37°C for 45 minutes. Next,
the sample was centrifuged at 1,400 rpm for 10 minutes,
the supernatant was discarded, and the pellet was plated
and cultured in T75 flasks containing basal culture
medium. The flasks were incubated in a 5% CO2 incuba-
tor at 37°C, and 48 hours later, the cells were washed with
0.15 M PBS. The culture medium was replaced twice per
week, and the cells were replated when 80-90% confluence
was reached.
The cells were phenotypically characterised for the
expression of CD90 (ab22541, Abcam, USA), CD29-PE
(ab64629, Abcam, MA, USA), CD45 (ab22514, Abcam,
MA, USA), and CD32-PE (ab42902, Abcam, MA, USA)
using a secondary antibody (ab6730, Abcam, MA, USA)
labelled with FITC for CD90 and CD45, according to
the manufacturer’s recommendations. The samples were
analysed using a FACScan (Fluorescence-Activated Cell
Analyser) flow cytometer and the Cell Quest software. A
total of 20,000 events were acquired with the FSC and
SSC parameters on the linear scale and the FL1 (for
FITC) and FL2 (for PE) parameters on the logarithmic
scale. The data were assessed with the WinMDI software
using dot plot charts.cription of canine BM-MSC and AD-MSC in DMEM (basal medium)
ation as measured by qRT-PCR. The data are expressed relative to
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After three rounds of replating, MSCs from each source
(BM-MSCs and AD-MSCs) were allocated randomly
into the following groups: 1) BM-MSCs in osteogenic
medium; 2) BM-MSCs in basal medium; 3) AD-MSCs in
osteogenic medium; and 4) AD-MSCs in basal medium.
The osteogenic medium was composed of the basal culture
medium supplemented with 10% FBS (Soralis, São Paulo,
Brazil) and enriched with ascorbic acid (50 μg/mL), ß-
glycerophosphate (10 mM) (Sigma-Aldrich, MO, USA),
and dexamethasone (0.1 μM) (Aché, São Paulo, Brazil).
The cells in all four groups were cultured in quadruplicate
at 37°C and 5% CO2 for 7, 14, and 21 days, and the
following parameters were then assessed: conversion of
MTT into formazan crystals, alkaline phosphatase (ALP)
activity, collagen synthesis, percentage of cells, area of
mineralised matrices per field, and relative expression of
gene transcripts of osterix (OSX), bone sialoprotein (BSP),
and osteocalcin (OC) using real-time reverse transcription
polymerase chain reaction (qRT-PCR).Conversion of MTT into formazan and alkaline
phosphatase activity
To perform the MMT conversion assay, MSCs from each
group were cultured separately in 24-well plates containing
DMEM (basal medium) or osteogenic medium. At each
time-point, the culture medium in each well was replaced
by 210 μL of basal medium and 170 μL of MTT (5 mg/
mL) (Invitrogen, CA, USA). The plates were incubated in a
5% CO2 incubator at 37°C for 2 hours. Formazan crystals
were observed under a microscope before the addition of
210 μL of SDS (sodium dodecyl sulphate)-10% HCl, and
the samples were left overnight in a 5% CO2 incubator at
37°C. Next, a 100 μL aliquot was taken from each well and
placed into 96-well plates to be read using a plate reader at
595 nm wavelength, according to Boeloni et al. [9].
To assess ALP activity, MSCs from each group were
cultured separately in 24-well plates containing DMEM
(basal medium) or osteogenic medium. At each time-point,
the cultures were washed with PBS (0.15 M). A total ofTable 1 Genes and nucleotide sequences of the primers used
Gene reference Primers (5’ to 3’ nucleotide sequen
GAPDH [12] Forward - CCATCTTCCAGGAGCGAGG
Reverse - TTCTCCATGGTGGTGAAGAC
Osteocalcin [5] Forward - GAGGGCAGCGAGGTGGTGA
Reverse - TCAGCCAGCTCGTCACAGTT
Bone sialoprotein (BSP) [12] Forward – TTGCTCAGCATTTTGGGAAT
Reverse - AACGTGGCCGATACTTAAAG
Osterix [5] Forward – ACGACACTGGGCAAAGCAG
Reverse – CATGTCCAGGGAGGTGTAG200 μL of BCIP/NBT solution (Zymed Laboratories, USA)
were added to each well, and the samples were incubated
in a 5% CO2 incubator at 37°C for 2 hours. The samples
were observed under an optical microscope before the
addition of 200 μL of SDS (sodium dodecyl sulphate)-10%
HCl and were left overnight in a 5% CO2 incubator at 37°C.
Next, a 100 μL aliquot was taken from each well and placed
into 96-well plates to be read using a spectrophotometer at
595 nm wavelength, according to Ocarino et al. [10].Collagen synthesis, percentage of cells, and mineralised
matrices
To assess collagen synthesis, MSCs from each group
were cultured separately in 24-well plates containing
DMEM (basal medium) or osteogenic medium. At each
time-point, the cultures were washed with PBS (0.15 M).
One mL of Bouin fixative was added to each well, and
the plates were incubated in a 5% CO2 incubator at 37°C
for 2 hours and left overnight in a refrigerator at 6°C. At
each time-point, the plates were washed four times with
reverse osmosis water and dried for subsequent staining
with Sirius Red for 30 minutes at room temperature.
Excess dye was removed, and the cells were washed
three times with 0.01 N HCl solution and dried. Next,
300 μL of 0.5 M NaOH was added, and the plates were
incubated for 30 minutes. A 100 μL aliquot was then
taken from each well and placed into 96-well plates to be
read using a spectrophotometer at 540 nm wavelength,
according to Boeloni et al. [20].
To assess the percentage of cells and mineralised
matrices per field, MSCs from each group were cultured
separately in six-well plates with sterile cover slips (22 ×
22 mm) containing DMEM (basal medium) or osteo-
genic medium. At each time-point, the cultures were
washed with 0.15 M PBS, fixed with 70% alcohol for
24 hours, and stained by the Von Kossa method adapted
from Prophet et al. [21]. The percentages of cells and
mineralised matrices per field were determined from 25
fields using an ocular micrometer comprising a 121-point
grid and 4× objective.in qRT-PCR
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differentiation
A commercial primary culture of canine osteoblasts (Abcam,
MA, USA) was used as positive control for osteogenic
differentiation. The cells were thawed according to the
manufacturer’s recommendations and cultured in T75
flasks containing the same media and under the same con-
ditions as BM-MSCs and AD-MSCs. The cultures resulting
from the third replating performed after reaching 80-90%
confluency were used for the extraction of total mRNA and
analysis of osterix, BSP, and OC expressions by qRT-PCR.
To perform relative quantification of the gene transcripts
for osterix, BSP, and OC by qRT-PCR, the MSCs of all
groups were cultured in quadruplicate in T25 flasks
containing DMEM (basal medium) or osteogenic medium.
At each time-point, total RNA was extracted from the
cultures using TRIzol® (Invitrogen, USA) according to the
manufacturer’s instructions. The RNA was solubilised in
RNAse-free DEPC water (Invitrogen, USA) and immedi-
ately stored at −80°C. RNA concentrations were measured
by reading the absorbance at 260/280 nm by spectro-
photometry. Reverse transcription was performed using
SuperScript™ III Platinum® Two-Step Kit (Invitrogen,
USA). The cDNA was synthesised using 1 μg of total RNA
in a total volume of 20 μL. Real-time PCR was performed
using 2 μg of cDNA, 5 pM of each primer, and 12.5 μL of
SYBR® Green reagent (Invitrogen, USA) in a total volume
of 25 μL per well using the 7500 Real-Time PCR System
(Applied Biosystems, USA). The parameters for amplifi-
cation were as follows: 50°C for 120 seconds, 95°C for
150 seconds, and 45 cycles of 95°C for 15 seconds and
60°C for 30 seconds. The primers were found in the
literature or designed based on the sequence of Canis
familiaris mRNA (Table 1). Gene expression was calcu-
lated using the 2-ΔΔCT method, whereby the results of
each individual group were compared after normalisation
to Canis familiaris glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) expression. The levels of gene
expression measured in the osteoblast cultures were used
as positive controls for osteogenic differentiation, and the
relative expression of each transcript was calculated based
on the expression standard.
Statistical analysis
Analysis of variance (ANOVA) was performed, and the
mean and standard deviation of each variable were calcu-
lated. Means were compared with the SNK test using
GraphPad InStat3 software (La Jolla, CA, USA). Changes in
expression found by qRT-PCR were compared using the
SNK test after logarithmic transformation of the data. The
significance level was established as p < 0.05 [22].
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